What is HMicro?
HMicro Inc. operates at the intersection of semiconductor innovation and medical device engineering. As a first-mover in the development of silicon-based wireless sensing platforms, the firm provides essential subsystem products that enable medical companies to accelerate their time-to-market. The company's core offerings, including WiPoint silicon, biosensor patches, and specialized access points, are engineered to meet the rigorous demands of modern clinical environments.
By focusing on high-integration and cost-effective manufacturing, HMicro addresses the critical need for disruptive, reliable data communication in healthcare. Their technology is specifically optimized for medical sensing, ensuring that manufacturers can develop distinctive products that maintain exceptional energy efficiency without compromising on performance or data integrity.
How much funding has HMicro raised?
HMicro has raised a total of $21.2M across 3 funding rounds:
Series B
$5.5M
Series B
$5.5M
Series C
$10.2M
Series B (2014): $5.5M with participation from X/Seed Capital Partners and Seraph Group
Series B (2014): $5.5M, investors not publicly disclosed
Series C (2016): $10.2M supported by UNIQUEST Infra Ventures, XSeed Capital, and Seraph Group
Key Investors in HMicro
XSeed Capital
XSeed Capital is an early stage investment firm that partners with entrepreneurs aiming to create category-leading, high growth companies. The firm focuses on supporting innovative startups in their growth journey.
UNIQUEST Infra Ventures
Uniquest Infra Ventures Private Limited is a subsidiary of UEM Group, focusing on the management and operation of significant infrastructure projects with a vision to become a premier global group.
Seraph Group
Seraph Group is a venture capital firm that provides strategic backing to technology-driven companies, focusing on long-term growth and market disruption.
What's next for HMicro?
With the backing of institutional partners, HMicro is well-positioned to expand its footprint in the global medical technology market. The recent capital injection is expected to fuel further research and development, specifically targeting the enhancement of its wireless sensing ecosystem and the scaling of manufacturing capabilities to meet rising enterprise demand.
Strategic priorities likely include deepening the integration of WiPoint technology into next-generation remote patient monitoring systems and expanding the company's technical support infrastructure. As the demand for reliable, small-form-factor medical data solutions continues to grow, HMicro's focus on high-reliability silicon will remain a key differentiator, enabling the firm to maintain its competitive edge in an increasingly connected healthcare landscape.
